Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

803 projects found matching your search criteria :

  1. Frog skin derived cyclic peptide as a molecular scaffold to create a novel tool for combining visualization and inhibiti...

    Call: PRELUDIUM 23 , Panel: ST5

    Principal investigator: Aleksandra Dorota Helbik-Maciejewska

    Uniwersytet Gdański

  2. Small molecule modulators of the tumor necrosis factor alpha signaling pathway for the inhibition of inflammatory proces...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Tadeusz Holak

    Uniwersytet Gdański

  3. (Lipid-FLUX) Single-cell lipidomics by spectroscopy: Quantification of the lipid transport through the development of ne...

    Call: OPUS 27 , Panel: ST4

    Principal investigator: prof. Małgorzata Anna Barańska

    Uniwersytet Jagielloński

  4. Synthesis of novel hybrid nanomaterials based on fullerene scaffold for photodynamic therapy of cancer

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Dominik Jakub Dreszer

    UNIWERSYTET ŚLĄSKI

  5. Precision double strike against non-small cell lung cancer. Insights into multidirectional therapies and the landscape o...

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr Katarzyna Anna Malarz

    Politechnika Śląska

  6. Evaluation of the relationship between doxorubicin resistance, epithelial-mesenchymal plasticity, and effects of selecte...

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Dominika Kunachowicz

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  7. Controlling the covalent activity of a PD-L1 inhibitors with light

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Wiktor Jan Uzar

    Uniwersytet Jagielloński

  8. EGR1 Protein: A Key Factor in Cellular Homeostasis?

    Call: PRELUDIUM 23 , Panel: NZ3

    Principal investigator: Marta Leśniczak-Staszak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  9. Metastasis process regulation by inhibiting neutrophils NETosis through phytocannabinoids and the endocannabinoid system

    Call: PRELUDIUM 23 , Panel: NZ1

    Principal investigator: Izabela Marianna Krauze

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  10. Proteomic predictors of metastasis in colorectal cancer – a validation study

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr hab. Anna Wojakowska

    Instytut Chemii Bioorganicznej PAN

  11. Is organ-on-a-chip technology able to reduce animal sacrifice in studies on radiosensitizers?

    Call: OPUS 27 , Panel: ST4

    Principal investigator: prof. Janusz Adam Rak

    Uniwersytet Gdański

  12. The Prognostic Utility of Circulating Tumor Cells (CTCs) Derived from the Portal Vein in Operable Colorectal Cancer Pati...

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Claudia Dompé

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  13. The role of gratitude induced with a multi-component intervention in improving mental health outcomes of breast cancer p...

    Call: SONATINA 8 , Panel: HS6

    Principal investigator: dr Joanna Tomczyk

    Uniwersytet im. Adama Mickiewicza w Poznaniu

  14. Profiling of the phageome in relation to clinical outcomes in patients undergoing radical cystectomy and urinary diversi...

    Call: SONATINA 8 , Panel: NZ6

    Principal investigator: dr Katarzyna Anna Gembara

    Wojewódzki Szpital Specjalistyczny we Wrocławiu. Ośrodek Badawczo-Rozwojowy

  15. Cellular senescence as a new mechanism in development and progression of head and neck cancer

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: prof. Michał Mateusz Masternak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  16. Defining the transcriptional and epigenetic state of tumor cells with increased plasticity and the epithelial-endothelia...

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr hab. Agnieszka Kobielak

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  17. In search for DNA methylation aberrations associated with susceptibility to ovarian cancer

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr Malwina Magdalena Suszyńska

    Instytut Chemii Bioorganicznej PAN

  18. To be or not to be modified: the role of single m6A sites of long noncoding RNAs in breast cancer

    Call: SONATA 19 , Panel: NZ5

    Principal investigator: dr Elżbieta Wanowska

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

  19. β4-integrin is a guardian of nuclear integrity and chromatin accessibility limitingprostate cancer progression

    Call: SONATA 19 , Panel: NZ2

    Principal investigator: dr Tomasz Jacek Wenta

    Uniwersytet Gdański, Wydział Biologii

  20. The role of oxidative stress, inflammation, disorders of purine metabolism, urea cycle and angiogenesis at the molecular...

    Call: SONATA 19 , Panel: NZ5

    Principal investigator: dr Paulina Wigner-Jeziorska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  21. Organometallic (Fe, Ru, Ir, Os) phospho-inducers of drug-resistant cancer cells' ferroptosis

    Call: OPUS 26 , Panel: ST4

    Principal investigator: dr hab. Urszula Katarzyna Komarnicka

    Uniwersytet Wrocławski, Wydział Chemii

  22. Protease-induced neutrophilic networks in cancer development.

    Call: SONATA 19 , Panel: NZ5

    Principal investigator: dr Danuta Teresa Bryzek

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  23. Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Magdalena Wujak

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

  24. Exploring the influence of genomic features on mutational signatures across tumors

    Call: OPUS 26 , Panel: NZ2

    Principal investigator: dr Damian Michał Wójtowicz

    Uniwersytet Warszawski, Wydział Matematyki, Informatyki i Mechaniki

  25. Mucoadhesive nanospheres as an intravesical form of monomethyl auristatin E

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Jelonek

    Centrum Materiałów Polimerowych i Węglowych PAN

  26. Integrated multi-omics approach to accelerate anticancer drug discovery by targeting metabolic reprogramming in human co...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Danuta Dudzik

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  27. Bacterial membrane carriers targeting tumor-associated microbes for advanced cancer therapy

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Monika Kluzek

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  28. Novel aspects of the mechanisms of vascular toxicity of tyrosine kinase inhibitors: studies on their proinflammatory act...

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr Tomasz Krzysztof Prajsnar

    Uniwersytet Jagielloński, Wydział Biologii

  29. Design and characterisation of sealing materials of prosthetic obturator being additionally a cytostatic drug reservoir....

    Call: OPUS 26 , Panel: ST8

    Principal investigator: prof. Anna Trusek

    Politechnika Wrocławska

  30. Vascular dysfunction after breast cancer neoadjuvant chemotherapy.The significance of menopausal status and estrogens.

    Call: SONATA 19 , Panel: NZ4

    Principal investigator: dr Piotr Szczepaniak

    Uniwersytet Jagielloński, Collegium Medicum

  31. Increasing sensitivity to immunotherapy in lung cancer via immunostimulation and modulation of tumor microenvironment

    Call: SONATA BIS 13 , Panel: NZ5

    Principal investigator: dr Urszula Oleksiewicz

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  32. Design and microfluidic synthesis of hybrid nanocarriers stabilized by novel sugar surfactants as a potential anticancer...

    Call: SONATA BIS 13 , Panel: ST4

    Principal investigator: dr hab. Urszula Jolanta Bazylińska

    Politechnika Wrocławska

  33. How is meiotic TEX12 re-activated in cancer and can we exploit this in the clinic?

    Call: SONATA BIS 13 , Panel: NZ3

    Principal investigator: dr Urszula Łucja Mcclurg

    Instytut Biologii Medycznej PAN

  34. Advanced statistical and deep learning models to predict cancer risk and support treatment decisions

    Call: SONATA BIS 13 , Panel: NZ2

    Principal investigator: dr Michał Marczyk

    Politechnika Śląska, Wydział Automatyki, Elektroniki i Informatyki

  35. XAICancer: Explainable Artificial Intelligence for Cancer Imaging

    Call: SONATA BIS 13 , Panel: ST6

    Principal investigator: dr Neo Christopher Chung

    Uniwersytet Warszawski, Wydział Matematyki, Informatyki i Mechaniki

  36. Extensive analysis of the immunological profile of pediatric patients with acute lymphoblastic leukemia in order to iden...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Anna Krętowska-Grunwald

    Uniwersytet Medyczny w Białymstoku

  37. Development of novel bifunctional ceramic coatings with osteoinductive and anti-oncogenic properties on metallic implant...

    Call: PRELUDIUM 22 , Panel: ST5

    Principal investigator: Balbina Karina Makurat-Kasprolewicz

    Politechnika Gdańska

  38. The mechanism of competition of mutant p53 gain-of-function and major oncogene CMYC in gastric cancer.

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Marcin Mikołaj Grochowski

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  39. Novel receptor materials for the construction of a bioelectronic nose for the rapid and efficient detection of lung canc...

    Call: OPUS 25 , Panel: ST5

    Principal investigator: prof. Wojciech Kamysz

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  40. Persistent luminescence thermometry of nano-phosphors and their biomedical potential

    Call: OPUS 25 , Panel: ST5

    Principal investigator: dr Justyna Anna Zeler

    Uniwersytet Wrocławski, Wydział Chemii

  41. Development of dual immuno-oligo- biosensors for monitoring and controlling of the metastatic colorectal cancer and inve...

    Call: OPUS 25 , Panel: ST4

    Principal investigator: dr hab. Magdalena Stobiecka

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

  42. Anticancer potential of TMPyP4 porphyrin in breast cancer photodynamic therapy and evaluation of the treatment safety

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Błażej Rubiś

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  43. Investigating mechanisms regulating ALCAM alternative splicing and susceptibility of this molecule to cleavage by shedda...

    Call: OPUS 25 , Panel: NZ2

    Principal investigator: dr Marta Karolina Wagner

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  44. Multifunctional emulsion-based transporters for personalised cancer treatment

    Call: OPUS 25 , Panel: ST8

    Principal investigator: prof. Ewa Dłuska

    Politechnika Warszawska, Wydział Inżynierii Chemicznej i Procesowej

  45. Predictive Potential of Circulating MicroRNA Biomarkers in Patients with High Familial or Genetic Risk of Cancer

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: prof. Wojciech Fendler

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  46. Quantitation of metabolic turnover in single cancer cells by infrared microscopy

    Call: OPUS 25 , Panel: NZ1

    Principal investigator: dr Luca Quaroni

    Uniwersytet Jagielloński, Wydział Chemii

  47. INVADOPODIA IN AXL-DRIVEN CANCER INVASION AND DRUG RESISTANCE

    Call: OPUS 25 , Panel: NZ3

    Principal investigator: dr Daria Paulina Zdżalik-Bielecka

    Uniwersytet Warszawski, Wydział Biologii

  48. Targeting Energy Metabolism for Precision Cancer Therapy: Novel Inhibitors of LDH-A and PDK1 as Potential Strategies to ...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Marika Anna Frańczak

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  49. Chiral hybrids of quinones and quinols with double anticancer and antimicrobial activity against drug-resistant pathogen...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Ryszard Józef Ostaszewski

    Instytut Chemii Organicznej Polska Akademia Nauk

  50. Investigating the anti-cancerous effect of antioxidant extract from spent coffee grounds on the functioning of normal an...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Adrianna Maria Piasek

    Politechnika Warszawska, Wydział Chemiczny